Director/PDMR Shareholding

RNS Number : 5116F

GlaxoSmithKline PLC

13 January 2010

 



 Notification of Transactions of Directors, Persons Discharging 

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 January 2010 of an increase in their notional interests in Ordinary shares at a price of £12.94 per share and Ordinary Share ADRs at a price of $41.48 per ADR following the notional re-investment of the dividend paid to shareholders on 7 January 2010.

	Ordinary shares	ADRs
Mr A P Witty	10,198.95
Mr J S Heslop	4,995.50
Dr M M Slaoui		2,618.17
Mrs C E Bruck Slaoui		72.54
Mr S M Bicknell	475.57
Mr J M Clarke	2,865.76
Mrs D P Connelly		920.23
Mr M Dunoyer	1,202.46
Mr E J Gray	1,363.65
Mr S A Hussain	1,456.88
Mr D Learmouth	790.88
Mr W C Louv		948.61
Mr D J Phelan		1,460.86
Dr D Pulman		1,109.95
Mr D S Redfern	640.89
Mr J R Stéphenne	1,264.42
Ms C Thomas	689.60
Mr D E Troy		1,399.24

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a). 

V A Whyte

Deputy Company Secretary

13 January 2010

 

END

 

 

RDSQXLFFBFFLBBF